MET signalling: principles and functions in development, organ regeneration and cancer
- PMID: 21102609
- DOI: 10.1038/nrm3012
MET signalling: principles and functions in development, organ regeneration and cancer
Abstract
The MET tyrosine kinase receptor (also known as the HGF receptor) promotes tissue remodelling, which underlies developmental morphogenesis, wound repair, organ homeostasis and cancer metastasis, by integrating growth, survival and migration cues in response to environmental stimuli or cell-autonomous perturbations. The versatility of MET-mediated biological responses is sustained by qualitative and quantitative signal modulation. Qualitative mechanisms include the engagement of dedicated signal transducers and the subcellular compartmentalization of MET signalling pathways, whereas quantitative regulation involves MET partnering with adaptor amplifiers or being degraded through the shedding of its extracellular domain or through intracellular ubiquitylation. Controlled activation of MET signalling can be exploited in regenerative medicine, whereas MET inhibition might slow down tumour progression.
Similar articles
-
Met endosomal signalling: in the right place, at the right time.Int J Biochem Cell Biol. 2014 Apr;49:69-74. doi: 10.1016/j.biocel.2014.01.009. Epub 2014 Jan 16. Int J Biochem Cell Biol. 2014. PMID: 24440758 Review.
-
Cellular and molecular mechanisms of HGF/Met in the cardiovascular system.Clin Sci (Lond). 2015 Dec;129(12):1173-93. doi: 10.1042/CS20150502. Clin Sci (Lond). 2015. PMID: 26561593 Review.
-
Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling.J Cell Physiol. 2006 Apr;207(1):271-85. doi: 10.1002/jcp.20564. J Cell Physiol. 2006. PMID: 16331688
-
C-MET as a new therapeutic target for the development of novel anticancer drugs.Clin Transl Oncol. 2010 Apr;12(4):253-60. doi: 10.1007/s12094-010-0501-0. Clin Transl Oncol. 2010. PMID: 20462834 Review.
-
Met, metastasis, motility and more.Nat Rev Mol Cell Biol. 2003 Dec;4(12):915-25. doi: 10.1038/nrm1261. Nat Rev Mol Cell Biol. 2003. PMID: 14685170 Review. No abstract available.
Cited by
-
Ligand-independent activation of MET through IGF-1/IGF-1R signaling.Int J Cancer. 2013 Oct 1;133(7):1536-46. doi: 10.1002/ijc.28169. Epub 2013 Apr 17. Int J Cancer. 2013. PMID: 23526299 Free PMC article.
-
3D Printing of a Vascularized Mini-Liver Based on the Size-Dependent Functional Enhancements of Cell Spheroids for Rescue of Liver Failure.Adv Sci (Weinh). 2024 May;11(17):e2309899. doi: 10.1002/advs.202309899. Epub 2024 Feb 21. Adv Sci (Weinh). 2024. PMID: 38380546 Free PMC article.
-
Novel c-Met inhibitory olive secoiridoid semisynthetic analogs for the control of invasive breast cancer.Eur J Med Chem. 2016 Aug 8;118:299-315. doi: 10.1016/j.ejmech.2016.04.043. Eur J Med Chem. 2016. PMID: 27258622 Free PMC article.
-
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network.Cancer Res Commun. 2024 Jul 1;4(7):1863-1880. doi: 10.1158/2767-9764.CRC-23-0370. Cancer Res Commun. 2024. PMID: 38957115 Free PMC article.
-
Receptor Tyrosine Kinase MET Interactome and Neurodevelopmental Disorder Partners at the Developing Synapse.Biol Psychiatry. 2016 Dec 15;80(12):933-942. doi: 10.1016/j.biopsych.2016.02.022. Epub 2016 Feb 26. Biol Psychiatry. 2016. PMID: 27086544 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous